Copyright
©The Author(s) 2003.
World J Gastroenterol. Jul 15, 2003; 9(7): 1618-1620
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1618
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1618
Table 1 Clinical variables in patients with breast cancer and controls
Variables | Cases (n = 217)Number (%) | Controls (n = 182)Number (%) | P |
Fatty liver | |||
No | 119 (54.8) | 145 (79.7) | |
Yes | 98 (45.2) | 37 (20.3) | < 0.0001 |
Overweight | |||
No | 93 (42.9) | 137 (75.3) | |
Yes | 124 (57.1) | 45 (24.7) | < 0.0001 |
Hyperlipidemia | |||
No | 177 (81.6) | 154 (84.6) | |
Yes | 40 (18.4) | 28 (15.4) | 0.432 |
Hepatitis C | |||
No | 204 (94.0) | 165 (90.6) | |
Yes | 13 (6.0) | 17 (9.4) | 0.144 |
Age | |||
Mean ± SD | 48.6 ± 10.5 | 46.8 ± 12.0 | 0.029 |
Table 2 Clinical factors associated with fatty liver in patients with breast cancer (n = 217)
Variables | Number of cases | P | |
Fatty Liver (-) | Fatty Liver (+) | ||
Contraceptives | |||
No | 117 | 94 | |
Yes | 2 | 4 | 0.28 |
Tamoxifen | |||
No | 25 | 13 | |
Yes | 94 | 85 | 0.14 |
Chemotherapy | |||
No | 52 | 49 | |
Yes | 58 | 47 | 0.59 |
Hepatitis C | |||
No | 116 | 88 | |
Yes | 10 | 3 | 0.031 |
Diabetes | |||
No | 113 | 92 | |
Yes | 6 | 6 | 0.73 |
Overweight | |||
No | 71 | 21 | |
Yes | 48 | 77 | < 0.0001 |
Hyperlipidemia | |||
No | 106 | 71 | |
Yes | 13 | 27 | 0.017 |
Table 3 Significant variables on multivariate analysis for patients with breast cancer
Variables | Coefficient estimates and significant test | |||
Coefficient | SD | P | Odds ratio | |
Overweight | 0.3410 | 0.0474 | 0.0000 | 1.406 4 |
Hyperlipidemia | 0.0263 | 0.0132 | 0.0473 | 1.2066 |
- Citation: Chu CH, Lin SC, Shih SC, Kao CR, Chou SY. Fatty metamorphosis of the liver in patients with breast cancer: Possible associated factors. World J Gastroenterol 2003; 9(7): 1618-1620
- URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1618.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i7.1618